Categories
pandemic

A Collection of Covid Links

I have been lax in writing lately. Maybe my posts about mental health have given you a small clue about why? Not so subtle hint… In the background, I’m still reading some news and research, but most of the links I find interesting just end up in a notes file loosely titled “pandemic.” Today, I decided that I could at least go back and share the stories I’ve found interesting enough to save over the last month. Some might be a little out of date, but I know you’ll excuse me.

Double Masking

Most recently, the CDC annouced some shocking news (to me!) about masking. According to this NPR article, “Double Masking Offers More Protection,” with the most common combo being a cloth mask over a disposable (paper) surgical mask. This apparently helps the masks fit tightly and seal any holes that might exist to keep out any stray aerosols. When both people in an “exposure” during research wore their mask according to newly recommended CDC standards, transmissions of covid was reduced by 95%. This is AS EFFECTIVE AS THE VACCINE.

New CDC mask fitting guidelines issued as of Wednesday, February 10, 2021.

So, wear a mask, or even better TWO MASKS!

A Covid Cure?

Monday, January 25, a group of scientists from UCSF announced promising research into the cancer drug Aplidin, currently only approved in Australian to treat multiple myeloma, but currently on limited trial in Spain for covid19. The anti-viral drug is 30 times more potent that the current standard treatment remdesivir. Aplidin, generic name plitidepsin, was discovered in a sea squirt called Aplidium albicans off the coast of Ibiza, Spain but is not commercially available in most of the world.

Read more about the research at “The UCSF-led team racing to find a COVID cure may have found a promising candidate

Will Covid End Homelessness?

This is the question Emma Gray Ellis asks for Wired Magazine in the article “The Lasting Impact of Covid-19 on Homelessness in the US.” She explores programs like California’s Project Roomkey, which utilized unused hotel rooms to house homeless people to curb the spread of covid among the homeless population by simply getting them off the street. And then the how the plan has transitioned to Project Homekey, which is attempting to turn these places into permanent housing for the homeless. Will attempts across the country to prevent widespread covid in the homeless population actually result in long-lasting change and housing? I really hope so, and some signs point to yes.

January in Santa Clara County ICUs

Its only February and yet January seems years away. It was a horrible post-holiday surge, and in the Bay Area, Santa Clara County was one of the hardest hit–as it was at the very beginning of the pandemic as well. This article about what it’s like inside the ICUs during the surge is fascinating reading, if you’re into that kind of thing.

Categories
pandemic

T minus 2 days

That’s when I’ll be vaccinated. I am very very excited to experience what will likely be the first in a long line of revolutionary new treatments pioneered with mRNA. I’m not quite as excited to likely be experiencing vaccine side effects over Christmas but oh well… I have a few days off so I might as well take some extra antihistamines and NSAIDs and sleep it off. I hope all of you are lucky enough to be getting vaccinated this holiday season as well!!!

Categories
Quick Notes

Is this the covid vaccine we’ve been waiting for?

The same weekend that we finally got election results, we had good news about a covid vaccine as well. The phase 3 trials are showing 90% effectiveness against the virus, which is so much more that we expected.

The vaccine [by Pfizer and partner BioNTech] is the first to be tested in the United States to generate late-stage data. The companies said an early analysis of the results showed that individuals who received two injections of the vaccine three weeks apart experienced more than 90% fewer cases of symptomatic Covid-19 than those who received a placebo.

Read more at Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate